Documents & Downloads

EAPB0202

Anticancer Agent

EAPB0202 is an imidazolium and quinoxaline derivative that functions as an anticancer agent. It exhibits significant cytotoxicity against the A375 human melanoma cell line, with an IC50 value of 2.35 μM. This compound serves as a valuable tool for cancer research, enabling investigations into mechanisms of action and potential therapeutic applications in oncology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	681284-82-2
Applications	Anticancer Agent
Formula	C₁₈H₁₆N₄
Molecular Weight	288.35
SMILES	NC1=NC2=C(N3C(CCC4=CC=CC=C4)=CN=C31)C=CC=C2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.